HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined infliximab and rituximab in necrotising scleritis.

Abstract
We report a patient with necrotising scleritis in whom infliximab was used for short-term steroid-sparing while rituximab took effect. This enabled disease control without requiring an extended period of high-dose corticosteroid administration or the concurrent use of cyclophosphamide.
AuthorsJiten Morarji, Lavnish Joshi, Oren Tomkins-Netzer, Sue Lightman, Simon R J Taylor
JournalCase reports in ophthalmology (Case Rep Ophthalmol) Vol. 3 Issue 3 Pg. 286-90 (Sep 2012) ISSN: 1663-2699 [Electronic] Switzerland
PMID23275790 (Publication Type: Case Reports)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: